I last wrote about Body Central (BODY) in early August shortly after the company reported its Q2 results. My thesis then was that the market had overreacted to the Q2 results which should have been expected to be horrid, leading to a 32% drop in a single day to around $8 per share. I thought the market had overreacted then, but since, the stock has descended another ~30%.
Altogether, the stock has gone from about $12.50 leading up to the Q2 results to $5.42 last Friday, down 57%. Since the release, there really hasn't been any news, leading me to wonder how this all happened. BODY is far closer to a turnaround than it...
Only subscribers can access this article, which is part of the PRO research library covering 3,592 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: